[1]
C. Caldarella, B. Muoio, M. A. Isgro’, E. Porfiri, G. Treglia, and L. Giovanella, “The role of fluorine-18-fluorodeoxyglucose positron emission tomography in evaluating the response to tyrosine-kinase inhibitors in patients with metastatic primary renal cell carcinoma.”, RO, vol. 48, no. 3, Aug. 2014.